Publication Cover
Inhalation Toxicology
International Forum for Respiratory Research
Volume 24, 2012 - Issue 6
199
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Safety assessment of nebulized xylitol in beagle dogs

, , , , , , , , & show all
Pages 365-372 | Received 14 Dec 2011, Accepted 01 Mar 2012, Published online: 08 May 2012

References

  • Alanen P, Holsti ML, Pienihäkkinen K. 2000. Sealants and xylitol chewing gum are equal in caries prevention. Acta Odontol Scand 58:279–284.
  • Autio JT, Courts FJ. 2000. Acceptance of the xylitol chewing gum regimen by preschool children and teachers in a Head Start program: a pilot study. Acta Odontol Scand 58:285–292.
  • Bär A. 1985. Safety assessment of polyolsweetners–Some aspects of toxicity. Food Chem 16:231–241.
  • Bär A. 1987. Toxicological aspects of sugar alcohols–Studies of xylitol. In:Leegwater DC, Feron VJ, Hermus RJJ, eds. Low Digestibility of Carbohydrates; Proceedings of Workshop held at the TNO-CIVO Institutes, Zeist, the Netherlands. 26–27 November 1986. Wageningen: Wageningen, Pudoc. 42–50.
  • Code of Federal Regulations - Title 21: Food and Drugs. Updated to Apr 1, 2011. Chpt 1; Subchapter B; Part 172; Subpart D; 172.395 - Xylitol.
  • Daviskas E, Anderson SD, Brannan JD, Chan HK, Eberl S, Bautovich G. 1997. Inhalation of dry-powder mannitol increases mucociliary clearance. Eur Respir J 10:2449–2454.
  • Daviskas E, Anderson SD. 2006. Hyperosmolar agents and clearance of mucus in the diseased airway. J Aerosol Med 19:100–109.
  • Daviskas E, Anderson SD, Jaques A, Charlton B. 2010. Inhaled mannitol improves the hydration and surface properties of sputum in patients with cystic fibrosis. Chest 137:861–868.
  • Donaldson SH, Bennett WD, Zeman KL, Knowles MR, Tarran R, Boucher RC. 2006. Mucus clearance and lung function in cystic fibrosis with hypertonic saline. N Engl J Med 354:241–250.
  • Dunayer EK. 2004. Hypoglycemia following canine ingestion of xylitol-containing gum. Vet Hum Toxicol 46:87–88.
  • Dunayer EK, Gwaltney-Brant SM. 2006. Acute hepatic failure and coagulopathy associated with xylitol ingestion in eight dogs. J Am Vet Med Assoc 229:1113–1117.
  • Durairaj L, Launspach J, Watt JL, Businga TR, Kline JN, Thorne PS, Zabner J. 2004. Safety assessment of inhaled xylitol in mice and healthy volunteers. Respir Res 5:13.
  • Durairaj L, Launspach J, Watt JL, Mohamad Z, Kline J, Zabner J. 2007. Safety assessment of inhaled xylitol in subjects with cystic fibrosis. J Cyst Fibros 6:31–34.
  • Durairaj, L, Sivillo, A, Thorne, PS, Zabner, J, Welsh, MJ, McDonald J, Reed, MD. 2009. Preclinical Safety Assessment of Inhaled Xylitol: Supporting Studies for Clinical Trials in Cystic Fibrosis (abstract #2058). The Toxicologist, CD – An official Journal of the Society of Toxicology, 108.
  • Eagon RG, Phibbs PVJr. 1971. Kinetics of transport of glucose, fructose, and mannitol by Pseudomonas aeruginosa. Can J Biochem 49:1031–1041.
  • Elkins MR, Robinson M, Rose BR, Harbour C, Moriarty CP, Marks GB, Belousova EG, Xuan W, Bye PT; National Hypertonic Saline in Cystic Fibrosis (NHSCF) Study Group. 2006. A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis. N Engl J Med 354:229–240.
  • Hayes C. 2001. The effect of non-cariogenic sweeteners on the prevention of dental caries: a review of the evidence. J Dent Educ 65:1106–1109.
  • Jannesson L, Renvert S, Kjellsdotter P, Gaffar A, Nabi N, Birkhed D. 2002. Effect of a triclosan-containing toothpaste supplemented with 10% xylitol on mutans streptococci in saliva and dental plaque. A 6-month clinical study. Caries Res 36:36–39.
  • Jaques A, Daviskas E, Turton JA, McKay K, Cooper P, Stirling RG, Robertson CF, Bye PT, Lesouëf PN, Shadbolt B, Anderson SD, Charlton B. 2008. Inhaled mannitol improves lung function in cystic fibrosis. Chest 133:1388–1396.
  • Mäkinen KK. 1976. Long-term tolerance of healthy human subjects to high amounts of xylitol and fructose: general and biochemical findings. Int Z Vitam Ernahrungsforsch Beih 15:92–104.
  • Mäkinen KK, Bennett CA, Hujoel PP, Isokangas PJ, Isotupa KP, Pape HR Jr, Mäkinen PL. 1995. Xylitol chewing gums and caries rates: a 40-month cohort study. J Dent Res 74:1904–1913.
  • Mauderly JL. 1972. Steady-state carbon monoxide-diffusing capacity of unanesthetized beagle dogs. Am J Vet Res 33:1485–1491.
  • Mauderly JL. 1979. Effect of age on pulmonary structure and function of immature and adult animals and man. Fed Proc 38:173–177.
  • Minasian C, Wallis C, Metcalfe C, Bush A. 2008. Bronchial provocation testing with dry powder mannitol in children with cystic fibrosis. Pediatr Pulmonol 43:1078–1084.
  • Minasian C, Wallis C, Metcalfe C, Bush A. 2010. Comparison of inhaled mannitol, daily rhDNase and a combination of both in children with cystic fibrosis: a randomised trial. Thorax 65:51–56.
  • Robinson M, Daviskas E, Eberl S, Baker J, Chan HK, Anderson SD, Bye PT. 1999. The effect of inhaled mannitol on bronchial mucus clearance in cystic fibrosis patients: a pilot study. Eur Respir J 14:678–685.
  • Schlesinger RB. 1985. Comparative deposition of inhaled aerosols in experimental animals and humans: a review. J Toxicol Environ Health 15:197–214.
  • Simons D, Brailsford S, Kidd EA, Beighton D. 2001. The effect of chlorhexidine acetate/xylitol chewing gum on the plaque and gingival indices of elderly occupants in residential homes. J Clin Periodontol 28:1010–1015.
  • Söderling E, Mäkinen KK, Chen CY, Pape HR Jr, Loesche W, Mäkinen PL. 1989. Effect of sorbitol, xylitol, and xylitol/sorbitol chewing gums on dental plaque. Caries Res 23:378–384.
  • Tapiainen T, Renko M, Kontiokari T, Uhari M. 2002. Xylitol concentrations in the saliva of children after chewing xylitol gum or consuming a xylitol mixture. Eur J Clin Microbiol Infect Dis 21:53–55.
  • Wills PJ. 2007. Inhaled mannitol in cystic fibrosis. Expert Opin Investig Drugs 16:1121–1126.
  • Zabner J, Seiler MP, Launspach JL, Karp PH, Kearney WR, Look DC, Smith JJ, Welsh MJ. 2000. The osmolyte xylitol reduces the salt concentration of airway surface liquid and may enhance bacterial killing. Proc Natl Acad Sci USA 97:11614–11619.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.